Pure Global
Disease/Condition
643 Clinical Trials
10+ Countries

Ovarian Cancer Clinical Trials Database - Free Access to 643 Studies

Access comprehensive clinical trial information for Ovarian Cancer through Pure Global AI's free database. This collection includes 643 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 127 trials are actively recruiting participants.

Research for Ovarian Cancer is being conducted in United States of America, China, France and 7+ other countries. Leading sponsors include M.D. Anderson Cancer Center and AstraZeneca. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Free Database
Powered by Pure Global AI
840K+ Global Trials
Updated Daily
By Phase
N/A
245
Phase 2
194
Phase 3
63
Phase 1
61
Early Phase 1
52
By Status
Completed
247
Recruiting
127
Not yet recruit...
82
Unknown
67
Terminated
57
Top Countries
United States of America190
China92
France32
Italy26
United Kingdom21
Top Sponsors
M.D. Anderson Canc...21
AstraZeneca14
National Cancer In...12
National Taiwan Un...10
Hoffmann-La Roche10
Recent Trials
Latest clinical trials for Ovarian Cancer
NCT06412120
Phase 4
Not yet recr...

Study Evaluating Safety, Tolerability, and Metabolism of Niraparib

University of MiamiUnited States of America
NCT06403072
Completed

(GI-RADS) in Preoperative Evaluation of Adnexal Masses

Beni-Suef UniversityEgypt
NCT06395844
Phase 1/2
Recruiting

Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer

Anhui Provincial Cancer Hospit...China
NCT06394492
Phase 3
Not yet recr...

SHR-A1921 for Injection in Patients With Platinum-Resistant Recurrent Epithelial Ovarian Cancer

Suzhou Suncadia Biopharmaceuti...China
NCT06377267
Phase 2
Recruiting

Status of HRD That Lead to a Benefit From Olaparib in Combination With Bevacizumab (STROBE Trial)

Vall d'Hebron Institute of Onc...Spain
NCT06366490
Phase 1
Not yet recr...

Safety and Immunogenicity of Innocell Autologous Cellular Immunotherapy in Recurrent Epithelial Ovarian Cancer

PhotonPharma, Inc.
NCT06317610
Recruiting

Artificial Intelligence Model for Growth Prediction of Ovarian Cancer Organoids

Chongqing University Cancer Ho...China
NCT06304922
Not yet recr...

BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary

Assiut University
NCT06298877
Recruiting

Frailty, Quality Of Life and Early Reversal of Temporary Defunctioning Stoma in Ovarian Cancer

Sahar SalehiSweden
NCT06379191
Completed

The Efficacy of WeChat-based Multidisciplinary Full-course Nutritional Management Program

Peking Union Medical College H...China
NCT06320418
Recruitment ...

The Epigenetic Regulatory Role of P-element Induced Wimpy Testis (Piwi) Interacting RNA-823 (piR-823) in Ovarian Cancer Progression

Ain Shams UniversityEgypt
NCT06283875
Not yet recr...

The Exploration of Personalized ctDNA Based MRD in the Clinical Significance of Cervical Cancer

Geneplus-Beijing Co. Ltd.China
NCT06324175
Recruiting

Spatial Radiogenomics of Ovarian Cancer: Implementation of a Lesion-specific 3D-printed Mould Pipeline in the Clinical Workflow for Image-guided Tissue Multi-sampling of Ovarian Tumours

Fondazione Policlinico Univers...Italy
NCT06253559
Completed

Clinical and Pathological Characteristics of Women With Ovarian Cancers in Syria

Tishreen UniversitySyrian
NCT06249308
Recruiting

Liquid Biopsy-based Early Detection of Ovarian Cancer: a Proof-of-concept Study ( PROFOUND-OC )

Fudan UniversityChina
NCT06240598
Phase 2
Recruiting

A Study of Second Look Laparoscopy (SLL) in People With Ovarian Cancer Who Have Completed Their First Course of Chemotherapy

Memorial Sloan Kettering Cance...United States of America
NCT06232122
Recruiting

Evaluation of 68Ga-FAPI-46 and 18F-FDG PET/CT Imaging for Detecting Recurrent Tumor Lesions in Patients of Ovarian Cancer

Chang Gung Memorial HospitalTaiwan
NCT06211023
Phase 2/3
Not yet recr...

A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer

Suzhou Suncadia Biopharmaceuti...
NCT06216496
Not yet recr...

Evaluation of Amino Acid Metabolism Changes in Ovarian Cancer

University Hospital, Grenoble
NCT06229522
Recruiting

Patients Derived Organoids as a Promising Tool to Tailor Ovarian Cancer Therapies (PANDORA).

Centro di Riferimento Oncologi...Italy
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
About Ovarian Cancer Research

Pure Global AI provides free access to 643 clinical trials studying Ovarian Cancer, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include M.D. Anderson Cancer Center, AstraZeneca, National Cancer Institute, Naples, among others.

Quick Facts
Total Trials643
Countries10+
Sponsors10+
Recruiting127